The McManus Group is a registered federal lobbying firm. For Q3 2026 it reported $1.23M across 23 client reports and lists 5 lobbyists across its filings. Issues include Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code and Budget/Appropriations.
| Client | Reported | Issues |
|---|---|---|
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | $90K | Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code |
| INFUSION PROVIDERS ALLIANCE | $90K | Health Issues, Medicare/Medicaid |
| BRISTOL-MYERS SQUIBB | $80K | Health Issues, Medicare/Medicaid |
| ACESSO BIOLOGICS | $60K | Medicare/Medicaid |
| ARDELYX | $60K | Medicare/Medicaid |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $60K | Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code |
| AMGEN | $60K | Medicare/Medicaid |
| AMBULATORY SURGERY CENTER ASSOCIATION | $60K | Health Issues, Medicare/Medicaid |
| GILEAD SCIENCES, INC. | $60K | Health Issues, Medicare/Medicaid |
| NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) | $60K | Health Issues, Medicare/Medicaid |
| VIVEX BIOLOGICS | $50K | Health Issues |
| BIOWOUND SOLUTIONS | $50K | Medicare/Medicaid |
| VIALASE INC. | $50K | Health Issues, Medicare/Medicaid |
| WEX HEALTH | $50K | Taxation/Internal Revenue Code |
| GENENTECH | $50K | Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code |
| ZIMMER BIOMET | $50K | Health Issues, Medicare/Medicaid |
| GRAIL, INC. | $50K | Medicare/Medicaid |
| ROCHE DIAGNOSTICS | $40K | Medicare/Medicaid |
| AMERICAN OCCUPATIONAL THERAPY ASSOCIATION | $40K | Medicare/Medicaid |
| OWLET | $30K | Budget/Appropriations, Health Issues |
| VENTURE MEDICAL | $30K | Medicare/Medicaid |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | $30K | Medicare/Medicaid, Trade (domestic/foreign) |
| DENDREON PHARMACEUTICALS LLC | $30K | Medicare/Medicaid, Veterans |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $3.87M | 27 |
| 2025 | $5.16M | 30 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.